Axovant's Parkinson's Gene Therapy Is Extremely Risky [Seeking Alpha]
Axon Enterprise, Inc. (AXON)
Last axon enterprise, inc. earnings: 2/7 04:15 pm
Check Earnings Report
US:NYSE Investor Relations:
investors.axovant.com/investors/sec-filings
Company Research
Source: Seeking Alpha
Summary Insanity: doing the same thing over and over again and expecting different results.” Albert Einstein The company Axovant Sciences ( AXON ) debuted in June 2015. The initial public offering raised $315 million. The stock climbed $14.90, or 99.3 percent to end its first trading day at $29.90. The offering valued Axovant at around $1.4 billion; it currently has a market capitalization of approximately $400 million. The company's majority shareholder, Roivant Sciences Ltd. (a non-public company), is led by Vivek Ramaswamy. Roivant licenses or purchases drugs from other companies that appear to have achieved some statistical significance, then sells these drugs to Axovant for further clinical development. Axovant has no basic research and development of its own. To date, Axovant has entered two drugs into trials and failed. Axovant has now pivoted to central nervous system gene therapy with a product whose initial clinical results couldn't be differentiat
Show less
Read more
Impact Snapshot
Event Time:
AXON
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
AXON alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
AXON alerts
High impacting Axon Enterprise, Inc. news events
Weekly update
A roundup of the hottest topics
AXON
News
- Axon Enterprise (AXON) Stock Sinks As Market Gains: What You Should Know [Yahoo! Finance]Yahoo! Finance
- Why Is Axon (AXON) Up 2.1% Since Last Earnings Report? [Yahoo! Finance]Yahoo! Finance
- Global Swarm Intelligence Market Analysis Report 2024: Ant Colony Optimization Leads Market with 45.0% Share in 2023 - Forecast to 2030 for the $300+ Million Industry [Yahoo! Finance]Yahoo! Finance
- 25 US States with the Highest Number of Police Officers Per Capita [Yahoo! Finance]Yahoo! Finance
- Beyond The TASER: How Axon Is Revolutionizing Public Safety (And Your Portfolio) [Seeking Alpha]Seeking Alpha
AXON
Earnings
- 2/27/24 - Beat
AXON
Sec Filings
- 3/28/24 - Form 4
- 3/18/24 - Form PRE
- 3/18/24 - Form 4
- AXON's page on the SEC website